The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Evangelos Briasoulis

Department of Medical Oncology

Ioannina University Hospital

Greece

[email]@otenet.gr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medical Oncology, Ioannina University Hospital, Greece. 1999 - 2010
  • University of Ioannina, Medical School, Medical Oncology Division, University Hospital of Ioannina, Greece. 2009
  • Ioannina University Hospital, Ioannina, Greece. 2008
  • Oncology Department, Section of Internal Medicine, Medical School of the University of Ioannina, and Medical Oncology Department, Greece. 2006
  • Department of Medical Oncology (EB), Greece. 2006

References

  1. Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study. Briasoulis, E., Golfinopoulos, V., Karina, M., Papakostas, P., Pavlidis, N., Fountzilas, G. Anticancer. Drugs (2010) [Pubmed]
  2. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer. Briasoulis, E., Pappas, P., Puozzo, C., Tolis, C., Fountzilas, G., Dafni, U., Marselos, M., Pavlidis, N. Clin. Cancer Res. (2009) [Pubmed]
  3. The dawn of Clinical Oncology education in Greece. Briasoulis, E., Kardamakis, D. J. BUON (2009) [Pubmed]
  4. Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study. Briasoulis, E., Fountzilas, G., Bamias, A., Dimopoulos, M.A., Xiros, N., Aravantinos, G., Samantas, E., Kalofonos, H., Makatsoris, T., Mylonakis, N., Papakostas, P., Skarlos, D., Varthalitis, I., Pavlidis, N. Cancer Chemother. Pharmacol. (2008) [Pubmed]
  5. CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature. Briasoulis, E., Kamposioras, K., Tzovaras, V., Pafitanis, G., Kostoula, A., Mavridis, A., Pavlidis, N. Lung. Cancer (2008) [Pubmed]
  6. Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction. Briasoulis, E., Karavasilis, V., Tzamakou, E., Piperidou, C., Soulti, K., Pavlidis, N. Anticancer. Drugs (2006) [Pubmed]
  7. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Briasoulis, E., Liakakos, T., Dova, L., Fatouros, M., Tsekeris, P., Roukos, D.H., Kappas, A.M. Expert. Rev. Anticancer. Ther (2006) [Pubmed]
  8. Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer. Briasoulis, E., Samantas, E., Kalofonos, H., Skarlos, D., Makatsoris, T., Christodoulou, C., Fountzilas, G., Bamias, A., Dimopoulos, M.A., Kosmidis, P., Pavlidis, N. Cancer Chemother. Pharmacol. (2005) [Pubmed]
  9. Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma. Briasoulis, E., Rontogianni, D., Karavasilis, V., Pavlidis, N. Thyroid (2005) [Pubmed]
  10. Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel. Briasoulis, E., Karavasilis, V., Tzamakou, E., Rammou, D., Soulti, K., Piperidou, C., Pavlidis, N. Cancer Chemother. Pharmacol. (2004) [Pubmed]
  11. Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Briasoulis, E., Karavasilis, V., Kostadima, L., Ignatiadis, M., Fountzilas, G., Pavlidis, N. Cancer (2004) [Pubmed]
  12. Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study. Briasoulis, E., Pentheroudakis, G., Timotheadou, H., Rammou, D., Pavlidis, N., Fountzilas, G. Anticancer. Drugs (2004) [Pubmed]
  13. Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature. Briasoulis, E., Tzouvara, E., Tsiara, S., Vartholomatos, G., Tsekeris, P., Bourantas, K. Breast. J (2003) [Pubmed]
  14. Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study. Briasoulis, E., Karavasilis, V., Tzamakou, E., Haidou, C., Piperidou, C., Pavlidis, N. Anticancer. Drugs (2002) [Pubmed]
  15. G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting. Briasoulis, E., Andreopoulou, E., Tolis, C.F., Bairaktari, E., Katsaraki, A., Dimopoulos, M.A., Fountzilas, G., Seferiadis, C., Pavlidis, N. Cancer (2001) [Pubmed]
  16. Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy. Briasoulis, E., Pavlidis, N. Oncologist (2001) [Pubmed]
  17. Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study. Briasoulis, E., Agnantis, N.J., Zagorianakou, P., Kamina, S., Gorezi, M., Pavlidis, N., Bai, M. J. Exp. Clin. Cancer Res. (2001) [Pubmed]
  18. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. Briasoulis, E., Kalofonos, H., Bafaloukos, D., Samantas, E., Fountzilas, G., Xiros, N., Skarlos, D., Christodoulou, C., Kosmidis, P., Pavlidis, N. J. Clin. Oncol. (2000) [Pubmed]
  19. Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support. Briasoulis, E., Froudarakis, M., Milionis, H.J., Peponis, I., Constantopoulos, S., Pavlidis, N. Respiration (2000) [Pubmed]
  20. Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration. Briasoulis, E., Karavasilis, V., Anastasopoulos, D., Tzamakou, E., Fountzilas, G., Rammou, D., Kostadima, V., Pavlidis, N. Ann. Oncol. (1999) [Pubmed]
 
WikiGenes - Universities